An MRI Radiomics Approach to Predict the Hypercoagulable Status of Gliomas.

Glioblastoma Multiforme glioma magnetic resonance imaging (MRI) radiomics tissue factor venous thromboembolism

Journal

Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829

Informations de publication

Date de publication:
26 Mar 2024
Historique:
received: 09 02 2024
revised: 16 03 2024
accepted: 22 03 2024
medline: 13 4 2024
pubmed: 13 4 2024
entrez: 13 4 2024
Statut: epublish

Résumé

Venous thromboembolic events are frequent complications of Glioblastoma Multiforme (GBM) and low-grade gliomas (LGGs). The overexpression of tissue factor (TF) plays an essential role in the local hypercoagulable phenotype that underlies these complications. Our aim was to build an MRI radiomics model for the non-invasive exploration of the hypercoagulable status of LGG/GBM. Radiogenomics data from The Cancer Genome Atlas (TCGA) and REMBRANDT (Repository for molecular BRAin Neoplasia DaTa) cohorts were used. A logistic regression model (Radscore) was built in order to identify the top 20% TF-expressing tumors, considered to be at high thromboembolic risk. The most contributive MRI radiomics features from LGG/GBM linked to high TF were identified in TCGA using Least Absolute Shrinkage and Selection Operator (LASSO) regression. A logistic regression model was built, whose performance was analyzed with ROC in the TCGA/training and REMBRANDT/validation cohorts: AUC = 0.87 [CI

Identifiants

pubmed: 38610968
pii: cancers16071289
doi: 10.3390/cancers16071289
pii:
doi:

Types de publication

Journal Article

Langues

eng

Auteurs

Zuzana Saidak (Z)

UR7516 CHIMERE, Université de Picardie Jules Verne, 80054 Amiens, France.
Service de Biochimie, Centre de Biologie Humaine, CHU Amiens, 80054 Amiens, France.

Adrien Laville (A)

INSERM UMR 1030, Gustave Roussy Cancer Campus, 94805 Villejuif, France.
Service de Radiothérapie, CHU Amiens, 80054 Amiens, France.

Simon Soudet (S)

UR7516 CHIMERE, Université de Picardie Jules Verne, 80054 Amiens, France.
Service de Médecine Vasculaire, CHU Amiens, 80054 Amiens, France.

Marie-Antoinette Sevestre (MA)

UR7516 CHIMERE, Université de Picardie Jules Verne, 80054 Amiens, France.
Service de Médecine Vasculaire, CHU Amiens, 80054 Amiens, France.

Jean-Marc Constans (JM)

UR7516 CHIMERE, Université de Picardie Jules Verne, 80054 Amiens, France.
Service d'Imagerie Médicale, CHU Amiens, 80054 Amiens, France.

Antoine Galmiche (A)

UR7516 CHIMERE, Université de Picardie Jules Verne, 80054 Amiens, France.
Service de Biochimie, Centre de Biologie Humaine, CHU Amiens, 80054 Amiens, France.

Classifications MeSH